Cardio Diagnostics Holdings is trading 5% down at $1.66, based on the supplied August 6, 2026 price context; no clear company-specific event directly explains the decline.
- An August 20 investor conference call will cover tests, studies, reimbursement, and growth initiatives.
- An SEC proxy filing is scheduled for distribution on August 7; neither event is explicitly linked to the decline.
- Healthcare is rising, so sector strength does not explain the drop.